Immunohistochemical analysis of NaPi2b protein (MX35 antigen) expression and subcellular localization in human normal and cancer tissues

Experimental Oncology

Volumn 33, Issue 3, 2011, Pages 157-161

  Kiyamova, R ^a   Shyian, M ^a,b   Lyzogubov, V V ^c   Usenko, V S ^c   Gout, T ^d   Filonenko, V ^a  

^a INSTITUTE OF MOLECULAR BIOLOGY AND GENETICS   (Ukraine)

^b TARAS SHEVCHENKO NATIONAL UNIVERSITY OF KYIV   (Ukraine)

^c Morphological Laboratory BIONTEC   (Ukraine)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Breast; Cancer; Lung cancer; Monoclonal antibody MX35; MX35 antigen; NaPi2b; Ovarian cancer

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY MX35; SODIUM PHOSPHATE COTRANSPORTER 2B; UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOMA; CANCER CELL; CANCER TISSUE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; OVARY CARCINOMA; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SCORING SYSTEM; TISSUE DISTRIBUTION;

BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; OVARIAN NEOPLASMS; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE IIB;

EID: 80053391211     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Rubin SC, Kostakoglu L, Divgi C, et al. Biodistribution and intraoperative evaluation of radiolabeled monoclonal antibody MX35 in patients with epithelial ovarian cancer. Gynecol Oncol 1993; 51: 61-6. (Pubitemid 23339265)
2. Andersson H, Cederkrantz E, Back T, et al. Intraperitoneal alpha-particle radioimmunotherapy of ovarian cancer patients: pharmacokinetics and dosimetry of (211)At-MX35 F(ab')2 - a phase I study. J Nucl Med 2009; 50: 1153-60.
3. Yin BW, Kiyamova R, Chua R, et al. Monoclonal antibody MX35 detects the membrane transporter NaPi2b (SLC34A2) in human carcinomas. Cancer Immun 2008; 8: 3.
4. Xu H, Bai L, Collins JF, et al. Molecular cloning, functional characterization, tissue distribution, and chromosomal localization of a human, small intestinal sodium-phosphate (Na+-Pi) transporter (SLC34A2). Genomics 1999; 62: 281-4. (Pubitemid 30053944)
5. Hilfiker H, Hattenhauer O, Traebert M, et al. Characterization of a murine type II sodium-phosphate cotransporter expressed in mammalian small intestine. Proc Natl Acad Sci USA 1998; 95: 14564-9. (Pubitemid 28549407)
6. Virkki LV, Biber J, Murer H, et al. Phosphate transporters: a tale of two solute carrier families. Am J Physiol Renal Physiol 2007; 293: 643-54.
7. Frei P, Gao B, Hagenbuch B, et al. Identification and localization of sodium-phosphate cotransporters in hepatocytes and cholangiocytes of rat liver. Am J Physiol Gastrointest Liver Physiol 2005; 288: 771-8.
8. Huber K, Muscher A, Breves G. Sodium-dependent phosphate transport across the apical membrane of alveolar epithelium in caprine mammary gland. Comp Biochem Phys 2007; 146: 215-22. (Pubitemid 46187117)
9. Homann V, Rosin-Steiner S, Stratmann T, et al. Sodiumphosphate cotransporter in human salivary glands: molecular evidence for the involvement of NPT2b in acinar phosphate secretion and ductal phosphate reabsorption. Arch Oral Biol 2005; 50: 759-68. (Pubitemid 40817367)
10. Traebert M, Hattenhauer O, Murer H, et al. Expression of a type II sodium-phosphate cotransporter in murine type II alveolar epithelial cells. Am J Physiol 1999; 277: 868-73.
11. Rangel LB, Sherman-Baust CA, Wernyj RP, et al. Characterization of novel human ovarian cancer-specific transcripts (HOSTs) identified by serial analysis of gene expression. Oncogene 2003; 22: 7225-32. (Pubitemid 37378555)
12. Shyian M, Gryshkova V, Kostianets O, et al. Quantitative analysis of SLC34A2 expression in different types of ovarian tumors. Exp Oncol 2011; 33: 1-5.
13. Kim HS, Kim do H, Kim JY, et al. Microarray analysis of papillary thyroid cancers in Korean. Korean J Intern Med 2010; 25: 399-407.
14. Chen DR, Chien SY, Kuo SJ, et al. SLC34A2 as a novel marker for diagnosis and targeted therapy of breast cancer. Anticancer Res 2010; 30: 4135-40.
15. Kopantzev EP, Monastyrskaya GS, Vinogradova TV, et al. Differences in gene expression levels between early and later stages of human lung development are opposite to those between normal lung tissue and non-small lung cell carcinoma. Lung Cancer 2008; 62: 23-34.
16. Gryshkova V, Goncharuk I, Gurtovyy V, et al. The study of phosphate transporter NAPI2B expression in different histological types of epithelial ovarian cancer. Exp Oncol 2009; 31: 37-42.
17. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9. (Pubitemid 17064313)
18. Mattes MJ, Look K, Furukawa K, et al. Mouse monoclonal antibodies to human epithelial differentiation antigens expressed on the surface of ovarian carcinoma ascites cells. Cancer Res 1987; 47: 6741-50. (Pubitemid 18019679)
19. Back T, Andersson H, Divgi CR, et al. 211At radioimmunotherapy of subcutane-ous human ovarian cancer xenografts: evaluation of relative biologic effectiveness of an alpha-emitter in vivo. J Nucl Med 2005; 46: 2061-7. (Pubitemid 46657454)
20. Elgqvist J, Andersson H, Back T, et al. Fractionated radioimmunotherapy of intraperitoneally growing ovarian cancer in nude mice with 211At-MX35 F(ab')2: therapeutic efficacy and myelotoxicity. Nuclear Med Biol 2006; 33: 1065-72. (Pubitemid 44791950)
21. Hultborn RAH, Bäck T, Divgi C, et al. Pharmacokinetics and dosimetry of 211at-MX35 F(ab')2 in therapy of ovarian cancer-preliminary results from an ongoing phase I study [abstract]. Cancer Biother Radiopharm 2006; 21: 373-81.
22. Ikegami M, Falcone A, Whitsett JA, et al. STAT-3 regulates surfactant phospholipid homeostasis in normal lung and during endotoxin-mediated lung injury. J Appl Physiol 2008; 104: 1753-60.
23. Xu Y, Yeung CH, Setiawan I, et al. Sodium-inorganic phosphate cotransporter NaPi2b in the epididymis and its potential role in male fertility studied in a transgenic mouse model. Biol Reprod 2003; 69: 1135-41. (Pubitemid 37173843)